Pulmatrix, Inc. (PULM) stock
PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.37+0.04 (+3.01%)
Close on Nov 17, 2026Market cap $5.00MP/E –Yield –
Pulmatrix total assets
Total assets on the balance sheet at the end of each period.
Pulmatrix's total assets was $2.36M at Sep 30, 2026. For fiscal 2025 it was $4.14M, down 58.4% from the year before. Over ten years it grew -21.2% a year on average. The highest annual figure on record is $58.82M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.14M | -58.4% |
| FY2024 | Dec 31, 2024 | $9.94M | -70.7% |
| FY2023 | Dec 31, 2023 | $33.96M | -17.1% |
| FY2022 | Dec 31, 2022 | $40.95M | -30.4% |
| FY2021 | Dec 31, 2021 | $58.82M | +54.4% |
| FY2020 | Dec 31, 2020 | $38.10M | +5.5% |
| FY2019 | Dec 31, 2019 | $36.10M | +145.2% |
| FY2018 | Dec 31, 2018 | $14.72M | -7.9% |
| FY2017 | Dec 31, 2017 | $15.98M | -4.1% |
| FY2016 | Dec 31, 2016 | $16.66M | -62.9% |
| FY2015 | Dec 31, 2015 | $44.87M | +2793.2% |
| FY2014 | Dec 31, 2014 | $1.55M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.36M | -52.6% |
| Q2 FY2026 | Jun 30, 2026 | $3.25M | -47.2% |
| Q1 FY2026 | Mar 31, 2026 | $4.50M | -44.2% |
| Q4 FY2025 | Dec 31, 2025 | $4.14M | -58.4% |
| Q3 FY2025 | Sep 30, 2025 | $4.98M | -56.7% |
| Q2 FY2025 | Jun 30, 2025 | $6.15M | -61.0% |
| Q1 FY2025 | Mar 31, 2025 | $8.05M | -73.5% |
| Q4 FY2024 | Dec 31, 2024 | $9.94M | -70.7% |
| Q3 FY2024 | Sep 30, 2024 | $11.51M | -68.7% |
| Q2 FY2024 | Jun 30, 2024 | $15.78M | -49.7% |
| Q1 FY2024 | Mar 31, 2024 | $30.39M | -15.7% |
| Q4 FY2023 | Dec 31, 2023 | $33.96M | -17.1% |
| Q3 FY2023 | Sep 30, 2023 | $36.77M | -20.8% |
| Q2 FY2023 | Jun 30, 2023 | $31.39M | -36.4% |
| Q1 FY2023 | Mar 31, 2023 | $36.06M | -33.6% |
| Q4 FY2022 | Dec 31, 2022 | $40.95M | -30.4% |
| Q3 FY2022 | Sep 30, 2022 | $46.45M | -16.7% |
| Q2 FY2022 | Jun 30, 2022 | $49.40M | -24.5% |
| Q1 FY2022 | Mar 31, 2022 | $54.30M | -22.3% |
| Q4 FY2021 | Dec 31, 2021 | $58.82M | +54.4% |
| Q3 FY2021 | Sep 30, 2021 | $55.75M | +29.8% |
| Q2 FY2021 | Jun 30, 2021 | $65.43M | +86.6% |
| Q1 FY2021 | Mar 31, 2021 | $69.85M | +126.6% |
| Q4 FY2020 | Dec 31, 2020 | $38.10M | +5.5% |
| Q3 FY2020 | Sep 30, 2020 | $42.96M | +30.5% |
| Q2 FY2020 | Jun 30, 2020 | $35.07M | -5.3% |
| Q1 FY2020 | Mar 31, 2020 | $30.82M | +120.3% |
| Q4 FY2019 | Dec 31, 2019 | $36.10M | +145.2% |
| Q3 FY2019 | Sep 30, 2019 | $32.93M | +102.2% |
| Q2 FY2019 | Jun 30, 2019 | $37.05M | +80.0% |
| Q1 FY2019 | Mar 31, 2019 | $13.99M | +1.9% |
| Q4 FY2018 | Dec 31, 2018 | $14.72M | -7.9% |
| Q3 FY2018 | Sep 30, 2018 | $16.29M | -15.7% |
| Q2 FY2018 | Jun 30, 2018 | $20.58M | -12.5% |
| Q1 FY2018 | Mar 31, 2018 | $13.72M | -39.8% |
| Q4 FY2017 | Dec 31, 2017 | $15.98M | -4.1% |
| Q3 FY2017 | Sep 30, 2017 | $19.33M | – |
| Q2 FY2017 | Jun 30, 2017 | $23.52M | – |
| Q1 FY2017 | Mar 31, 2017 | $22.79M | – |
| Q4 FY2016 | Dec 31, 2016 | $16.66M | – |
See a number that looks wrong?